Safety and Performance of New 1-piece Ostomy Product
Investigating the Safety and Performance of New 1-piece Ostomy Product Concepts Compared With SenSura 1-piece in Subjects With an Ileostomy
1 other identifier
interventional
65
1 country
1
Brief Summary
The aim of the the current investigation is to develop new soft and more flexible 1-piece ostomy products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 22, 2013
CompletedFirst Posted
Study publicly available on registry
February 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedResults Posted
Study results publicly available
May 30, 2014
CompletedApril 14, 2017
March 1, 2017
3 months
February 22, 2013
April 27, 2014
March 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of Leakage
The degree of leakage is measured using a 4-point leakage scale developed by Coloplast A/S at every baseplate change. The subjects had to tick off one of the following choices: 1. No leakage 2. Starting to leak 3. Leakage 4. Sudden Leakage
one week
Study Arms (3)
Treatment sequence 1
EXPERIMENTALThe subjects randomised to Treatment sequence 1 are going to test 1. Coloplast Adhesive baseplate A (A) 2. Coloplast Adhesive baseplate B (B) 3. SenSura 1-piece (S) The subjects test the three test products in a randomised order: ABS; BSA; SAB
Treatment sequence 2
EXPERIMENTALThe subjects randomised to Treatment sequence 2 are going to test 1. Coloplast Adhesive baseplate B (B) 2. Coloplast Adhesive baseplate C (C) 3. SenSura 1-piece (S) The subjects test the three test products in a randomised order: CBS; BSC; SCB
Treatment sequence 3
EXPERIMENTALThe subjects randomised to Treatment sequence 3 are going to test 1. Coloplast Adhesive baseplate A (A) 2. Coloplast Adhesive baseplate B (C) 3. SenSura 1-piece (S) The subjects test the three test products in a randomised order: ACS; CSA; SAC
Interventions
Coloplast Adhesive baseplate A is a newly developed 1-piece ostomy appliance.
Coloplast Adhesive baseplate B is a newly developed 1-piece ostomy appliance
Coloplast Adhesive baseplate C is a newly developed 1-piece ostomy appliance
SenSura 1-piece is the commercial CE-marked Coloplast 1-piece SenSura .
Eligibility Criteria
You may qualify if:
- Have given written informed consent and signed letter of authority form.
- Be at least 18 years of age and have full legal capacity.
- Be able to handle the bags themselves.
- Have an ileostomy with a diameter between 15 and 40 mm.
- Have had their ostomy for at least three months.
- Currently use a 1-piece flat ostomy appliance with open bag.
- Use minimum 1 ostomy appliance every second day.
- Be suitable for participation in the investigation and for using standard adhesive, flat base plate.
- Must be able to use a custom cut ostomy appliance.
- Accept to test three 1-piece ostomy appliances in the investigation.
- Negative result of a pregnancy test for women of childbearing age (only DK).
You may not qualify if:
- Use irrigation during the study (flush the stoma with water).
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
- Currently receiving or have within the past months received local or systemic steroid treatment in the peristomal area.
- Are pregnant or breastfeeding.
- Participating in other interventional clinical investigations or have previously participated in this investigation.
- Currently using ostomy belt.
- Currently using extended wear product.
- Known hypersensitivity towards any of the test products
- Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse) -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Holtedam 3
Humlebæk, 3050, Denmark
Results Point of Contact
- Title
- Marian Sinvani
- Organization
- Coloplast A/S
Study Officials
- PRINCIPAL INVESTIGATOR
Birte Jakobsen, Dr.
Coloplast A/S
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2013
First Posted
February 28, 2013
Study Start
February 1, 2013
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
April 14, 2017
Results First Posted
May 30, 2014
Record last verified: 2017-03